Record Annual and Fourth Quarter Sales in 2019
Total sales of $1.43B, an increase of 9.7% vs prior yearHigh design, high margin Lifestyle segment exceeds half a billion […]
Havertys Announces Fourth Quarter and Full Year 2019
ATLANTA, Feb. 18, 2020 (GLOBE NEWSWIRE) — HAVERTYS (NYSE: HVT and HVT.A) reported today sales of $213.8 million for the […]
Palomar Holdings, Inc. Reports Fourth Quarter & Full Year 2019 Results
LA JOLLA, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) — Palomar Holdings, Inc. (NASDAQ:PLMR) (“Palomar” or the “Company”) reported net income […]
New Stratus Energy Announces Completion of Shares for Debt Transaction
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESBay Street News
Dynavax to Present at the Cowen 40th Annual Health Care Conference
EMERYVILLE, Calif., Feb. 18, 2020 (GLOBE NEWSWIRE) — Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company focused on developing and […]
Kura Oncology to Report Fourth Quarter and Full Year 2019 Financial Results
SAN DIEGO, Feb. 18, 2020 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the […]
FedNat to Participate in the Raymond James 41st Annual Institutional Investors Conference
SUNRISE, Fla., Feb. 18, 2020 (GLOBE NEWSWIRE) — FedNat Holding Company (NASDAQ: FNHC) (“FedNat” or the “Company”), a super-regional insurance […]
ImmuCell Announces Unaudited Financial Results for the Year Ended December 31, 2019
PORTLAND, Maine, Feb. 18, 2020 (GLOBE NEWSWIRE) — ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company […]
Trevi Therapeutics Announces Election of James V. Cassella, Ph.D. to Board of Directors
NEW HAVEN, Conn., Feb. 18, 2020 (GLOBE NEWSWIRE) — Trevi Therapeutics, Inc. (“Trevi”), a clinical-stage biopharmaceutical company focused on the […]
ShotSpotter Reports Fourth Quarter and Full Year 2019 Financial Results
Company Achieves Third Consecutive Quarter of Profitability with Net Income of $1.3 Million and Adjusted EBITDA1 of $3.2 MillionNEWARK, Calif., […]
